Aldeyra Therapeutics

^{Priced, Nasdaq: ALDX}

Clinical-stage biotech developing treatments for rare skin and eye diseases.

Industry: Health Care

First Day Return: -10.0%

ALDX

Clinical-stage biotech developing treatments for rare skin and eye diseases.

IPO News for Aldeyra Therapeutics

Aldeyra Therapeutics prices IPO at $8, below the range 05/02/14
4 US IPOs planned for the week of Apr 28 04/28/14
Rare disease biotech Aldeyra Therapeutics cuts proposed IPO deal size by 47% 04/25/14

IPO Data
IPO Date	05/01/2014
Offer Price	IPO Intelligence Only
Price Range	IPO Intelligence Only
Offer Shares (mm)	IPO Intelligence Only
Deal Size ($mm)	$12
Lock-Up Date	IPO Intelligence Only
Street Research	IPO Intelligence Only

Underwriters
IPO Intelligence Only

Company Data
Website www.aldexatherapeutics.com
Headquarters	Burlington, MA, United States
Founded	2004
Employees at IPO	2

IPO News for Aldeyra Therapeutics

Aldeyra Therapeutics prices IPO at $8, below the range 05/02/14
4 US IPOs planned for the week of Apr 28 04/28/14
Rare disease biotech Aldeyra Therapeutics cuts proposed IPO deal size by 47% 04/25/14

Aldeyra Therapeutics (ALDX) Performance